Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 7 of 15

 
 

ADMA Biologics (NASDAQ:ADMA)

Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$21.25 (6.1% Downside)

About ADMA Biologics

ADMA Biologics logoADMA Biologics, Inc, a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/8/2024HC WainwrightBoost Price TargetBuy ➝ Buy$18.00 ➝ $26.00
11/8/2024Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$18.00 ➝ $25.00
10/14/2024HC WainwrightReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
9/20/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$20.00 ➝ $20.00
8/12/2024HC WainwrightBoost Price TargetBuy ➝ Buy$10.00 ➝ $18.00
8/9/2024Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$15.00 ➝ $20.00
7/9/2024Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$10.00 ➝ $15.00
6/20/2024MizuhoBoost Price TargetBuy ➝ Buy$12.00 ➝ $14.00
5/10/2024Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$8.00 ➝ $10.00
5/10/2024Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$8.00 ➝ $10.00
 

Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW